Introduction: Vitamin K Antagonist are large molecular therapy used in Africa to treat cardiologic illnesses .The aim of this study was to evaluate how the clinical laboratory supports safe and effective monitoring of patients on vitamin K antagonists (VKAs) at Hôpital de la Pai...
Open access
Research Article10.9734/ahrj/2025/v8i4215
Kalilou Diallo, Lamine Mané, Ludmillie Annie Badji, Mame Ngoné Coly, Habibou SARR, Bruce Shinga Wembulua, Emmanuel Nicolas Cabral, Ansoumana Diatta & Noel Magloire Manga·Asian Journal of Research in Infectious Diseases·2024
Background: Untreated smear-positive pulmonary tuberculosis constitutes the main source of transmission of the disease in the community. Aims: The aim of our study was to determine the diagnosis delays of smear-positive pulmonary tuberculosis in adults and to identify the factors...
Open access
Research Article10.9734/ajrid/2024/v15i2331
Introduction: Lipoprotein (a) is made up of an atherogenic LDL lipoparticle and a potentially thrombogenic apoprotein a and is therefore responsible for cardiovascular disease. The objective of this study is to evaluate serum lipoprotein (a) status and to investigate the correlat...
Open access
Research Article10.9734/ijbcrr/2024/v33i3862
Background: Sickle cell disease is an inherited disorder of hemoglobin. It poses a public health problem in Senegal and mainly affects children and adolescents. Infections are the main cause of morbidity and mortality in children with sickle cell disease. The objective of our wor...
Open access
Research Article10.9734/ajpr/2021/v6i430203
Kalilou Diallo, Dame Mbengue, Habibou SARR, Abdou Badiane, Khadidiatou Diallo, Mame Ngoné Coly, Ludmillie Annie Badji, Bruce Shinga Wembulua, Khardiata Diallo, Ansoumana Diatta & Noel Magloire Manga·Asian Journal of Research in Infectious Diseases·2024
Background: In 2020, Senegal began a transition to a Dolutgravir-based treatment as a first-line regimen in all new ART initiators in accordance with WHO recommendations. Aims: To determine the virological suppression and the tolerance on patients under a dolutegravir-based regim...
Open access
Research Article10.9734/ajrid/2024/v15i3336